RISING MEDICAID COSTS PEGGED TO ANTIDEPRESSANT Rxs

JULY 01, 2006

A sharp increase in prescriptions for pricey antidepressant drugs is driving up the cost of the Medicaid drug program at an alarming rate, said researchers at the Agency for Healthcare Research and Quality.

In the 5 years from 1997 to 2002, the cost of Medicaid drugs more than doubled from $11.6 billion to $23.7 billion. Overall spending on Medicaid outpatient drugs increased by 20% a year, the researchers reported. A key factor in that increase is that the number of Medicaid beneficiaries taking antidepressants climbed by 50% during the course of the 5-year study, while spending for these medications shot up by 130%.

The investigators also found that increasing rates of prescribing for cyclooxygenase-2 inhibitors, proton pump inhibitors, and cholesterol-lowering medications are driving up Medicaid costs.



SHARE THIS SHARE THIS
0

Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 

 

Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.